Report a Correction
If you believe a page is wrong -- an incorrect interaction, an outdated or broken source, an incorrect drug or supplement identity, or wording that's misleading -- please tell us. A person reviews every report before anything changes; nothing is published automatically from a submission.
Corrections log
When a genuine content error is found and fixed, it's recorded here with a date -- not just quietly changed. This log only lists real corrections to previously authored content; it isn't padded with routine new-content additions.
2026-08-25
Melatonin + Warfarin: corrected a missed source statement
The record stated NCCIH's melatonin safety page “does not mention warfarin anywhere” and classified the pair as insufficient evidence. Re-verifying the page directly during a Tier A/B content audit found that although warfarin isn't named by name, the page's safety section does state that “people with epilepsy and those taking blood thinner medications need to be under medical supervision when taking melatonin supplements” -- and warfarin is the textbook anticoagulant (“blood thinner”). The record was corrected to reflect this class-level caution and its severity was upgraded from insufficient evidence to monitor. The same missed statement was also identified and applied to the aspirin + melatonin record, since aspirin is a well-established antiplatelet “blood thinner.”
/interactions/melatonin-and-warfarin/interactions/aspirin-and-melatonin
2026-08-24
Ashwagandha + Escitalopram: reworded evidence description
The record originally described a 2025 finding as a “published case report.” It is actually a single case described in an American Academy of Neurology conference abstract, which is not peer-reviewed the way a published case report is. The record was reworded to say exactly that -- a single reported case in an unreviewed conference abstract -- so the evidence strength isn't overstated. Identified and fixed during pre-publication QA, before this content went live.
2026-08-24
Aspirin + Ibuprofen: removed a generic timing number
The record originally gave a single “wait 120 minutes” spacing instruction, sourced from one specific product's (extended-release aspirin) dosing directions alone. Aspirin's real FDA-documented timing relationship with ibuprofen depends on the aspirin formulation (immediate-release vs. enteric-coated) and which drug is taken first, so one universal number was inaccurate for other formulations. The generic interval was removed and replaced with a prose explanation of the formulation-dependent nuance, plus a pointer to ask a pharmacist about the specific product involved. Identified and fixed during pre-publication QA, before this content went live.
/interactions/aspirin-and-ibuprofen/guides/aspirin-and-ibuprofen-timing